NOB can significantly increase the chemosensitivity of ABCB1-overexpressed ovarian cancer cells and paclitaxel-resistant lung cancer cells to paclitaxel, doxorubicin, docetaxel, and daunorubicin and reverse MDR [38]. The gene discussed is ABCB1; the disease is ovarian carcinoma.